DexCom's stock narrative has shifted as analysts lower their fair value estimate from $98.40 to $84.96, marking a significant downward revision in the price target. This adjustment is primarily driven ...

Each green bar signals unusually large volumes in COHR shares. They reflect our proprietary inflow signal, pushing the stock higher: Source: Plenty of technology names are under accumulation right ...